Evidence map›Paper›PMID 37470155›Full record

ArticleHaematologica2023

Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia.

Ibrahim Aldoss, Parastou Tizro, Davsheen Bedi, James K Mangan, Mary C Clark, David Spencer, Joo Y Song, Sindhu Cherian, Raju Pillai, Young Kim and 8 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Ibrahim AldossDepartment of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA. ialdoss@coh.org.
Parastou TizroDepartment of Pathology, City of Hope, Duarte, CA.
Davsheen BediDepartment of Pathology, University of California San Diego, La Jolla, CA.
James K ManganDepartment of Medicine, Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, CA.
Mary C ClarkDepartment of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA.
David SpencerDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
Joo Y SongDepartment of Pathology, City of Hope, Duarte, CA.
Sindhu CherianDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Raju PillaiDepartment of Pathology, City of Hope, Duarte, CA.
Young KimDepartment of Pathology, City of Hope, Duarte, CA.
Nitin MahajanWugen, Saint Louis, MO.
Ketevan GendzekhadzeHLA Laboratory, City of Hope, Duarte, CA.
Mike JamesWugen, Saint Louis, MO.
Kenneth JacobsWugen, Saint Louis, MO.
Jan Davidson-MoncadaWugen, Saint Louis, MO.
Stephen J FormanDepartment of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA.
Huan-You WangDepartment of Pathology, University of California San Diego, La Jolla, CA.
Michelle AfkhamiDepartment of Pathology, City of Hope, Duarte, CA.
City of Hope · USUniversity of California, San Diego · USUniversity of Washington · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Precursor T-Cell Lymphoblastic Leukemia-LymphomaReceptors, Chimeric AntigenAntigens, CD19Cell- and Tissue-Based TherapyCell LineageHumansImmunotherapy, AdoptiveT-LymphocytesAntigens, CD19Receptors, Chimeric Antigen

Identifiers

PMID37470155
PMCPMC10690902
OpenAlexW4384819815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.